Lobbying

Spina Bifida Association's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.

Spina Bifida Association

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Spina Bifida Association lobbying by quarter
Spina Bifida Association lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$30K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$30K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$20K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Health issues$180K · 10 reports
  • Budget and appropriations$115K · 8 reports
  • Medical research and clinical labs$85K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Centers For Disease Control & Prevention (CDC)7 reports
  • Centers For Medicare and Medicaid Services (CMS)4 reports

Firms it paid

Firm
Venable$230K8 quarters
Powers Pyles Sutter & Verville, P.C.$150K7 quarters

Former officials lobbying for it

Former position
BART STUPAKU.S. Representative, 1993-2011Q3 2024

Lobbying reports

Filed by
07/14for Q2Powers Pyles Sutter & Verville, P.C.$20K
04/20for Q1Powers Pyles Sutter & Verville, P.C.$20K
02/11for Q4 2025Powers Pyles Sutter & Verville, P.C.$20K
25/10/20for Q3 2025Powers Pyles Sutter & Verville, P.C.$20K
25/07/21for Q2 2025Powers Pyles Sutter & Verville, P.C.$20K
25/04/21for Q1 2025Powers Pyles Sutter & Verville, P.C.$30K
25/01/21for Q4 2024Powers Pyles Sutter & Verville, P.C.$20K
24/10/28for Q4 2024Powers Pyles Sutter & Verville, P.C.Under $5,000
24/10/15for Q3 2024Venable$20K
24/07/22for Q2 2024Venable$20K
24/07/22for Q1 2024Venable$20K
24/04/17for Q1 2024Venable$30K
24/01/20for Q4 2023Venable$20K
23/10/16for Q3 2023Venable$30K
23/07/19for Q2 2023Venable$40K
23/04/20for Q1 2023Venable$40K
23/01/19for Q4 2022Venable$40K